Novacyt S.A. (AIM:NCYT)

Market Cap	29.49M
Revenue (ttm)	19.63M
Net Income (ttm)	-41.76M
Shares Out	n/a
EPS (ttm)	-0.59
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	77,303
Average Volume	108,214
Open	41.50
Previous Close	42.25
Day's Range	40.75 - 42.12
52-Week Range	36.00 - 137.00
Beta	n/a
RSI	41.96
Earnings Date	May 30, 2025

About Novacyt

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 234
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: NCYT

Financial Performance

In 2024, Novacyt's revenue was 19.63 million, an increase of 84.82% compared to the previous year's 10.62 million. Losses were -41.76 million, 47.6% more than in 2023.